Agenus IncAgenus Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The page contains a free Environmental, Social and Governance analysis for Agenus Inc. If you work at Agenus Inc and you would like to licence your Sustainability rating, please contact us. This dashboard contains a Q&A table on Agenus Inc.

Agenus Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 6.4, social score of 4.8 and governance score of 1.3.

SDG Transparency Score for Agenus Inc 
Low
0 - 3

4.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Agenus Inc 
6.4

Environmental

4.8

Social

1.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1284Sinopep Allsino Bio Pharmaceutical Co Ltd
4.4
High
1284Vanda Pharmaceuticals Inc
4.4
High
1335Agenus Inc
4.3
High
1335Angion Biomedica Corp
4.3
High
1335AddLife AB
4.3
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Agenus Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Agenus Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Agenus Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Agenus Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Agenus Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Agenus Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Agenus Inc offer flexible work?

LockedSign up for free to unlock

Does Agenus Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Agenus Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Agenus Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Agenus Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Agenus Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Agenus Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Agenus Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Agenus Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Agenus Inc disclose water use targets?

LockedSign up for free to unlock

Does Agenus Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Agenus Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Agenus Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Agenus Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Agenus Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Agenus Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Agenus Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Agenus Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Agenus Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Agenus Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Agenus Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Agenus Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Agenus Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Agenus Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Agenus Inc disclose its waste policy?

LockedSign up for free to unlock

Does Agenus Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Agenus Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Agenus Inc disclose energy use targets?

LockedSign up for free to unlock

Does Agenus Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Agenus Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Agenus Inc
These potential risks are based on the size, segment and geographies of the company.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 monospecific antibody that is in Phase 1 clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1777, an anti-TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody. In addition, the company develops INCAGN1876, an anti-GITR monospecific antibody; INCAGN1949, an anti-OX40 monospecific antibody; INCAGN2390, an anti-TIM-3 monospecific antibody; INCAGN2385, an anti-LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4; AGENT 797, an iNKT cells that is in Phase 1 clinical trial for solid tumors, multiple myeloma, and viral ARDS, as well as in clinical stage to treat hematological malignancies and multiple myeloma/B cells; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. Agenus Inc. operates under ASV, Agenus, AutoSynVax, EVAMPLIX, MiNK, PSV, PhosPhoSynVax, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Incyte Corporation, Merck Sharpe & Dohme, Recepta Biopharma SA, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Sorry!

Failed to process!